Cardiometabolic
Blood Pressure on a GLP-1
Your blood pressure falls as your weight does, which is a benefit right up until the point where the dose set at your old weight becomes too much. Nobody schedules the review, and the symptom of missing it is a fall.
This is the most predictable event in the whole treatment and the one most likely to go unmanaged, because nothing about it announces itself. Your blood pressure improves quietly over months, and the tablet you have taken every morning for six years quietly becomes too much.
How much it falls
Weight reduction lowers blood pressure — a relationship established long before these drugs, with meta-analysed estimates in the region of 1 mmHg of systolic reduction per kilogram lost in the earlier literature.
The GLP-1 trials report mean systolic reductions in the region of 5–7 mmHg at weight-management doses, with smaller diastolic falls. That is a meaningful population effect, roughly comparable to adding a low-dose antihypertensive, and individual responses vary widely around the mean.
Most of it tracks the weight rather than a direct vascular action, which means it accumulates over months. Do not expect much at week four, and do expect the picture at month eight to be different from the one your prescription was written for.
The failure mode
Not the drug. The unchanged prescription.
An antihypertensive dose appropriate at 105 kg is frequently too much at 88 kg. The result is orthostatic hypotension — the room tilting when you stand — and it develops so gradually that people adapt to it, stand up more carefully, and never mention it.
In an older adult, that symptom is not an inconvenience. It is a fall, and a fall in someone whose bone density has fallen with their weight is a fracture. The reasoning is in taking a GLP-1 after 65 and the bone health rankings.
Deprescribing here is the expected consequence of successful treatment. Clinicians do it routinely. What is not routine, and should be, is scheduling it in advance rather than waiting for a symptom.
What usually comes down, and what usually does not
This is your prescriber’s decision and it helps to understand the shape of it.
| Class | Typical position as weight falls |
|---|---|
| Thiazide diuretics | Often reduced or stopped early |
| Calcium channel blockers | Commonly reduced |
| ACE inhibitors / ARBs | Reduced for blood pressure — but often kept for kidney protection or after a heart attack |
| Beta blockers | Often kept if prescribed for rate control or post-infarction, not simply for blood pressure |
| Alpha blockers | Frequently reduced |
The point of that table is the middle row. Blood pressure medication is not always prescribed for blood pressure. An ACE inhibitor in someone with diabetic kidney disease is doing a job that does not stop because a reading improved — see GLP-1s and kidney disease.
Which is why “my blood pressure is normal now so I stopped my tablets” is a sentence that sometimes precedes a serious problem.
Which device to buy — and why the cuff that fitted in January may be wrong by October — is in the blood pressure monitor rankings.
Home monitoring, done properly
A single clinic reading is a poor instrument, and it is usually all a prescriber has. Home readings are what let them reduce a dose confidently rather than cautiously.
The method matters:
- A validated upper-arm cuff, correctly sized. Not a wrist device.
- Sit quietly for 5 minutes first. Back supported, feet flat, arm supported at heart level.
- No caffeine, exercise or smoking in the preceding 30 minutes, and no alcohol for 12 hours.
- Take 2 readings a minute apart, and record both.
- Morning and evening for 7 days. Discard day one. Average the rest.
Take that average to the appointment. It is worth more than anything measured in a corridor.
Also worth measuring: a standing reading after sitting, one minute apart, if you have felt light-headed. A drop on standing is the specific finding that argues for reducing a dose.
Where this overlaps with everything else
Dizziness has three common causes here and they are managed differently: over-treated blood pressure, dehydration, and — if you take insulin or a sulfonylurea — hypoglycemia. Distinguishing them is the whole subject of the dizziness piece.
Sodium cuts both ways. High-sodium electrolyte products are genuinely useful for someone whose intake has collapsed and are a clinical decision in hypertension, heart failure or kidney disease. Adding a gram of sodium to counteract a tablet that should be reduced is treating the wrong end — the electrolytes rankings.
Diuretics are on the sick-day hold list. During any illness with vomiting or diarrhea, that combination is how avoidable kidney injury happens — sick day rules.
Sleep apnea raises blood pressure, and treating it lowers it. If your blood pressure is stubborn despite treatment, that is one of the questions worth asking — GLP-1s and sleep apnea.
What to ask for
- A scheduled review — every 3 months through active weight loss, not “come back if you feel unwell”
- Agreement on which medication comes down first, and why
- Whether any of your antihypertensives are being taken for something other than blood pressure
- 7 days of home readings before each review
- A standing blood pressure if you have been light-headed
- Your sick day plan for the diuretic and any ACE inhibitor or ARB
None of that is unusual to ask for, and asking is what converts a predictable problem into a scheduled one.
Questions I get about this month
- How much does a GLP-1 lower blood pressure?
- Trials report mean systolic reductions in the region of 5 to 7 mmHg with semaglutide and tirzepatide at weight-management doses, with smaller diastolic falls. That is a meaningful effect at population level — comparable to adding a low-dose antihypertensive — and individual responses vary widely around it. Most of the benefit tracks the weight loss rather than a direct vascular effect, so it accumulates over months rather than appearing in the first weeks.
- Will I be able to stop my blood pressure tablets?
- Many people reduce them and some stop them entirely, and it is a decision for your prescriber rather than for you. Blood pressure medication is not always prescribed only for blood pressure — ACE inhibitors and ARBs are used for kidney protection in diabetes and after heart attacks, and beta blockers for rate control or after cardiac events. Those indications do not disappear because your reading improved, which is why the medication list is reviewed rather than simply reduced from the top.
- Why am I dizzy when I stand up on a GLP-1?
- Most often because your blood pressure medication is now too strong for your current weight, and less often because of dehydration from reduced fluid intake. Both are common and both are fixable. If you take insulin or a sulfonylurea, low blood sugar is a third possibility that feels similar and is managed completely differently. The important point is that light-headedness is a reason to get the medication reviewed rather than something to adapt to.
- How should I monitor my blood pressure at home?
- Use a validated upper-arm cuff rather than a wrist device, sit quietly for five minutes first, feet flat and arm supported at heart level, and take two readings a minute apart. Do this morning and evening for seven days, discard the first day, and average the rest. That average is far more useful to your prescriber than a single clinic reading, and it is what makes a confident dose reduction possible rather than a cautious one.
Sources
- 01Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). NEJM, 2021.
- 02Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). NEJM, 2022.
- 03Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). NEJM, 2023.
- 04Whelton PK et al. 2017 ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Hypertension, 2018.
- 05Neter JE et al. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension, 2003.
Elise Hall, MD
Board-certified internist in Los Angeles, twenty-one years in practice. She writes about GLP-1 medications and metabolic health for people who want the reasoning, not just the conclusion — and publishes her own year on one of these drugs alongside it.
Keep reading
Supplements
The Best Supplements for GLP-1 Hair Loss
The shedding starts two to four months after the loss speeds up, which is why almost nobody connects the two. Seven supplements ranked — and one of them interferes with the blood test that rules out a heart attack.
Supplements
Best Bone Health Supplements on a GLP-1
Bone is the tissue nobody thinks about until a wrist breaks. Rapid weight loss reduces bone mineral density, the effect is largest in exactly the people most likely to be prescribed these drugs, and none of it produces a symptom until it does.
Tools
The Best GLP-1 Apps, Ranked
I scored every tracker I could get my hands on against seven criteria that matter specifically on a GLP-1 — not generic calorie counting. Here is the ranking, the rubric behind it, and where my first choice falls short.